Declining R ates o f E xtracapsular E xtension A fter R adical Prostatectomy: E vidence f or C ontinued S tage M igration
暂无分享,去创建一个
H. Levin | E. Klein | C. Zippe | P. Kupelian | F. Jhaveri
[1] T. Stamey,et al. Histological and clinical findings in 896 consecutive prostates treated only with radical retropubic prostatectomy: epidemiologic significance of annual changes. , 1998, The Journal of urology.
[2] H. Levin,et al. Initial dissection of the lateral fascia reduces the positive margin rate in radical prostatectomy. , 1998, Urology.
[3] M. Kattan,et al. Has there been a recent shift in the pathological features and prognosis of patients treated with radical prostatectomy? , 1997, The Journal of urology.
[4] A W Partin,et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.
[5] A. Partin,et al. Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. , 1997, The Urologic clinics of North America.
[6] J. Epstein. Incidence and significance of positive margins in radical prostatectomy specimens. , 1996, The Urologic clinics of North America.
[7] H. Levin,et al. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. , 1996, Urology.
[8] C. Smart,et al. The fall in incidence of prostate carcinoma: On the down side of a prostate specific antigen induced peak in incidence‐‐Data from the Utah Cancer Registry , 1996, Cancer.
[9] A. Partin,et al. Prediction of progression following radical prostatectomy. A multivariate analysis of 721 men with long-term follow-up. , 1996, The American journal of surgical pathology.
[10] M. Kattan,et al. Prognostic significance of positive surgical margins in radical prostatectomy specimens. , 1995, The Journal of urology.
[11] H. Adami,et al. The value of prostate specific antigen in early diagnosis of prostate cancer: the study of men born in 1913. , 1995, The Journal of urology.
[12] M. Stampfer,et al. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. , 1995, JAMA.
[13] P. Knekt,et al. Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancer , 1994, The Lancet.
[14] P. Scardino,et al. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? , 1994, The Journal of urology.
[15] J. Oesterling,et al. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer. , 1994, The Journal of urology.
[16] W. Catalona,et al. 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. , 1994, The Journal of urology.
[17] A W Partin,et al. Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years. , 1993, The Urologic clinics of North America.
[18] R. Kane,et al. Characteristics of prostate cancers detected in a multimodality early detection program , 1993 .
[19] W. Catalona,et al. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. , 1993, JAMA.
[20] D. Chan,et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. , 1993, The Journal of urology.
[21] E. Klein,et al. Early continence after radical prostatectomy. , 1992, The Journal of urology.
[22] E. Metter,et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. , 1992, JAMA.
[23] P. Humphrey,et al. Histologic Grade, DNA Ploidy, and Intraglandular Tumor Extent as Indicators of Tumor Progression of Clinical Stage B Prostatic Carcinoma: A Direct Comparison , 1991, The American journal of surgical pathology.
[24] W. Catalona,et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. , 1991, The New England journal of medicine.
[25] J. Oesterling,et al. Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. , 1988, The Journal of urology.
[26] R L Vessella,et al. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer. , 1987, The Journal of urology.
[27] T. Stamey,et al. Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate , 1987 .
[28] I. Thompson,et al. Adenocarcinoma of the prostate: results of routine urological screening. , 1984, The Journal of urology.
[29] G. Murphy,et al. The national survey of prostate cancer in the United States by the American College of Surgeons. , 1982, The Journal of urology.
[30] R. Kane,et al. The results of a five‐year early prostate cancer detection intervention , 1996, Cancer.